Louisiana · 81171

Gene Analysis (fragile X Mental Retardation 2) For Abnormal Alleles in Louisiana

Louisiana Medicare Avg
$134.26
0% above national avg
National Medicare Avg
$134.13
All states combined
Billed Charge (LA)
$155.71
What providers submit
Est. Commercial (LA)
$302.08
National avg: $300.45
Est. Cash / Self-Pay (LA)
$143.52
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

63
Services in LA
2
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Louisiana

Provider Medicare Services
Align Laboratories, Llc $134.26 48
Cornerstone Diagnostics Llc $134.26 15

Louisiana Pricing in Context

In Louisiana, CPT code 81171 (Gene Analysis (fragile X Mental Retardation 2) For Abnormal Alleles) carries an average Medicare payment of $134.26 — 0% above the national benchmark of $134.13. 2 providers across the state submitted claims for this procedure in 2023, performing 63 total services. Individual payments in LA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Louisiana is $155.71, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Louisiana sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Genetic/Molecular Test procedures, the estimated commercial insurance price in Louisiana lands near $302.08, with self-pay cash prices typically around $143.52. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Gene Analysis (fragile X Mental Retardation 2) For Abnormal Alleles cost in Louisiana?

The average Medicare payment for Gene Analysis (fragile X Mental Retardation 2) For Abnormal Alleles in Louisiana is $134.26, which is 0% above the national average of $134.13. Providers in LA typically bill $155.71 for this procedure.

What does Gene Analysis (fragile X Mental Retardation 2) For Abnormal Alleles cost with insurance in Louisiana?

With commercial insurance in Louisiana, Gene Analysis (fragile X Mental Retardation 2) For Abnormal Alleles costs an estimated $302.08. Without insurance, the estimated cash price is $143.52. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Gene Analysis (fragile X Mental Retardation 2) For Abnormal Alleles in Louisiana?

2 providers in Louisiana billed Medicare for Gene Analysis (fragile X Mental Retardation 2) For Abnormal Alleles in 2023, performing 63 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Gene Analysis (fragile X Mental Retardation 2) For Abnormal Alleles cheaper in Louisiana than the national average?

No — Gene Analysis (fragile X Mental Retardation 2) For Abnormal Alleles costs 0% above the national average in Louisiana. The state average Medicare payment is $134.26 compared to $134.13 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial